Hearing Impairment, Sensorineural
9
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Clinical Evaluation of the RH210 Hearing Aid
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Understanding Aided Speech Perception in Noise
A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation and Sound Coding in Adults.
CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology
A Study Protocol for the Validation of UAud in a Clinical Setting.
Auditory Training and Hearing Aid Satisfaction
Auditory Training Via Teleconference
Cochlear Response Telemetry and Hearing Preservation